Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review
Background:. In some hidradenitis suppurativa (HS) clinical trial study arms, there is an unexpected decline in efficacy between the penultimate visit and the prespecified primary endpoint week, which we have termed a "wobble." Objective:. We aimed to establish how often study arms in HS p...
Saved in:
Main Authors: | Corey L. Snyder, MD (Author), Ruby S. Gibson, MD (Author), Stella X. Chen, MD (Author), Martina L. Porter, MD (Author), Alexa B. Kimball, MD, MPH (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study
by: Ruby S. Gibson, MD, et al.
Published: (2024) -
Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa
by: Ruby S. Gibson, MD, et al.
Published: (2022) -
Evaluating minority representation across health care settings in hidradenitis suppurativa and psoriasis
by: Charlotte Greif, MD, et al.
Published: (2024) -
Response to: Remission of hidradenitis suppurativa after bariatric surgery
by: Nicole Mona Golbari, BA, et al.
Published: (2018) -
Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study
by: Diana S. Kim, BA, et al.
Published: (2022)